ViaDerma Inc (VDRM)

[bjw5364]

I got my initial 250,000 buy here at $.026 last week and will add heavily as funds become available. The company is way ahead of most OTC stocks and growing. Johnson and Johnson made $150,000,000 in sales for Neosporin in 2019. This appears to be a superior product with more uses and the licensing angle with the patents gives it even more potential. The product reviews are great. I see a buyout down the road. I can definitely see this $.02 stock heading to $.50 or more either way.